×
  • Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    North America Cosmetic Surgery Market

    ID: MRFR/HC/14649-HCR
    128 Pages
    Rahul Gotadki
    October 2025

    North America Cosmetic Surgery Market Research Report Information By Procedure (Surgical Procedures and Non-surgical Procedures), By Gender (Female and Male), By Age Group (18 years and younger, 19 to 34 years, 35 to 50 years, 51 to 64 years and 65 years & above), By Provider (Hospitals & Specialty Clinics and Spas & Cosmetic Surgery Centers) –and North America Market Forecast Till 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    North America Cosmetic Surgery Market Infographic
    Purchase Options

    North America Cosmetic Surgery Market Summary

    As per MRFR analysis, the North America cosmetic surgery market Size was estimated at 21.5 USD Billion in 2024. The North America cosmetic surgery market is projected to grow from 23.15 USD Billion in 2025 to 48.5 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 7.68% during the forecast period 2025 - 2035.

    Key Market Trends & Highlights

    The North America cosmetic surgery market is experiencing a notable shift towards minimally invasive procedures and personalized treatments.

    • The US remains the largest market for cosmetic surgery, driven by a growing acceptance of aesthetic procedures.
    • Canada is emerging as the fastest-growing region, reflecting an increasing demand for non-surgical options.
    • There is a marked trend towards personalization in cosmetic procedures, influenced by social media and consumer preferences.
    • Technological advancements and rising disposable income are key drivers propelling the market forward.

    Market Size & Forecast

    2024 Market Size 21.5 (USD Billion)
    2035 Market Size 48.5 (USD Billion)

    Major Players

    Allergan (US), Galderma (CH), Revance Therapeutics (US), Medytox (KR), Hugel (KR), Ipsen (FR), Medytox (KR), Sientra (US), Croma-Pharma (AT)

    North America Cosmetic Surgery Market Trends

    The cosmetic surgery market in North America is currently experiencing a dynamic evolution, driven by a combination of technological advancements, changing societal norms, and increasing consumer awareness. The rise of minimally invasive procedures has transformed the landscape, appealing to a broader demographic. Patients are increasingly seeking options that offer quicker recovery times and less visible scarring, which has led to a surge in demand for non-surgical treatments. Furthermore, the influence of social media and celebrity culture appears to play a significant role in shaping public perceptions and desires regarding aesthetic enhancements. As individuals become more informed about available procedures, the market is likely to see continued growth and diversification in offerings. In addition, the cosmetic surgery market is witnessing a shift towards personalized experiences, with practitioners focusing on tailored solutions that meet individual needs. This trend is indicative of a broader movement towards patient-centric care, where the emphasis is placed on understanding and addressing specific concerns. Moreover, the increasing acceptance of cosmetic procedures among various age groups suggests a potential for sustained expansion. As the market adapts to these evolving preferences, it may also face challenges related to regulatory standards and ethical considerations, which will require ongoing attention from stakeholders in the industry.

    Rise of Minimally Invasive Procedures

    The cosmetic surgery market is seeing a notable increase in the popularity of minimally invasive procedures. These options, which often involve less recovery time and reduced risk of complications, are appealing to a wider audience. As techniques improve, patients are more inclined to choose these alternatives over traditional surgical methods.

    Personalization in Cosmetic Procedures

    There is a growing trend towards personalized cosmetic procedures, where practitioners tailor treatments to meet the unique needs of each patient. This shift reflects a broader emphasis on patient satisfaction and individualized care, allowing for more effective and targeted outcomes.

    Influence of Social Media

    Social media platforms are significantly impacting the cosmetic surgery market by shaping public perceptions and desires. The visibility of aesthetic enhancements through influencers and celebrities encourages individuals to consider procedures, thereby driving demand and altering societal norms surrounding beauty.

    North America Cosmetic Surgery Market Drivers

    Influence of Aging Population

    The aging population in North America serves as a pivotal driver for the cosmetic surgery market. As the demographic landscape shifts, a larger segment of the population is seeking cosmetic procedures to address age-related concerns. Reports indicate that individuals aged 50 and above account for nearly 40% of all cosmetic surgeries performed, highlighting the demand for anti-aging treatments. This trend is likely to persist as the baby boomer generation continues to age, with many individuals desiring to maintain a youthful appearance. The increasing focus on health and wellness among older adults further amplifies this demand, as they seek procedures that enhance their quality of life. Consequently, the cosmetic surgery market is expected to adapt and expand its offerings to cater to this growing demographic, ensuring that it meets the evolving needs of an aging clientele.

    Expansion of Non-Surgical Options

    The expansion of non-surgical options within the cosmetic surgery market is a notable trend that is reshaping consumer preferences. Treatments such as injectables, fillers, and skin rejuvenation procedures have gained immense popularity due to their minimal downtime and lower costs compared to traditional surgical options. Recent statistics reveal that non-surgical procedures now account for over 60% of the total cosmetic procedures performed, indicating a significant shift in consumer choice. This trend is particularly appealing to younger demographics who may be hesitant to undergo invasive surgeries. As practitioners continue to innovate and improve non-surgical offerings, the market is likely to see sustained growth. The increasing availability and acceptance of these alternatives suggest that the cosmetic surgery market will continue to evolve, catering to a broader audience seeking effective yet less invasive solutions.

    Increasing Acceptance of Cosmetic Procedures

    The growing acceptance of cosmetic procedures among various demographics is a notable driver in the cosmetic surgery market. As societal norms evolve, more individuals view cosmetic enhancements as a means of self-improvement rather than vanity. This shift is particularly evident among younger generations, with a reported increase of 30% in procedures among individuals aged 18-34 in recent years. The normalization of cosmetic surgery through media representation and celebrity endorsements further contributes to this trend. As acceptance rises, the market is likely to expand, with more individuals seeking surgical and non-surgical options to enhance their appearance. This cultural shift not only influences consumer behavior but also encourages practitioners to innovate and diversify their offerings, thereby stimulating growth in the cosmetic surgery market.

    Rising Disposable Income and Consumer Spending

    The increase in disposable income among consumers in North America is a significant driver of the cosmetic surgery market. As individuals experience higher earnings, they are more inclined to invest in personal aesthetics. Recent data indicates that consumer spending on cosmetic procedures has risen by approximately 15% over the past few years, reflecting a growing willingness to allocate funds towards enhancing one's appearance. This trend is particularly pronounced among middle to upper-income brackets, where individuals prioritize self-care and personal image. The correlation between economic prosperity and spending on cosmetic enhancements suggests that as the economy continues to improve, the cosmetic surgery market may experience sustained growth. This financial empowerment allows consumers to explore a wider range of options, further fueling demand for various cosmetic procedures.

    Technological Advancements in Surgical Techniques

    Technological advancements play a crucial role in shaping the cosmetic surgery market. Innovations such as 3D imaging, robotic-assisted surgery, and minimally invasive techniques have transformed the landscape of cosmetic procedures. These advancements not only enhance the precision and safety of surgeries but also reduce recovery times, making procedures more appealing to potential clients. For instance, the introduction of laser technology has led to a 25% increase in the popularity of skin resurfacing treatments. As technology continues to evolve, it is expected that the market will witness further growth, with new techniques emerging that cater to the demands of a more informed and discerning clientele. This ongoing evolution in surgical technology is likely to drive competition among practitioners, ultimately benefiting consumers in the cosmetic surgery market.

    Market Segment Insights

    By Procedure Type: Invasive (Largest) vs. Non-Invasive (Fastest-Growing)

    In the North America cosmetic surgery market, the invasive procedure segment currently holds the largest share, as it encompasses a wide range of established surgical options, such as liposuction and breast augmentation. These procedures have continued to dominate consumer preferences due to their lasting results and effectiveness. On the other hand, non-invasive procedures are rapidly gaining ground, appealing particularly to younger demographics seeking less invasive options. As awareness grows, the distribution of market share is shifting towards non-invasive procedures, highlighting a significant change in consumer behavior. The growth trends for these two segments illustrate a fascinating dichotomy in consumer choice. The invasive segment benefits from a long-standing reputation and proven results, fostering trust among patients. However, the non-invasive realm is becoming increasingly attractive due to technological advancements, lower recovery times, and enhanced safety profiles. As more consumers prioritize convenience and minimal downtime, this emerging segment is set to expand swiftly, with innovative treatment options likely to drive further growth in the coming years.

    Invasive (Dominant) vs. Non-Invasive (Emerging)

    Invasive procedures are characterized by surgical techniques that require incisions, leading to more significant alterations in appearance, which some consumers prefer for long-lasting results. This segment is viewed as dominant due to its established reputation and the comprehensive nature of the procedures involved. On the other hand, non-invasive procedures, which utilize techniques such as injectables and laser treatments, are categorized as emerging due to their rising popularity. They offer a safer, less painful alternative with quicker recovery times, appealing especially to younger adults. The shift toward non-invasive options highlights evolving consumer preferences, driven by a desire for effective yet minimally invasive treatments, making this segment a key player in future market dynamics.

    By End User: Hospitals and Dermatology Clinics (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing)

    The market share distribution in the End User segment reveals that Hospitals and Dermatology Clinics hold a substantial majority, catering to a wide range of cosmetic surgery needs with their advanced facilities and specialized staff. In contrast, Ambulatory Surgical Centers are emerging as pivotal players, providing less complex surgeries and benefiting from lower operational costs, which makes them an attractive option for patients seeking efficiency and convenience. Growth trends indicate that Ambulatory Surgical Centers are experiencing rapid expansion, driven by increased consumer demand for outpatient procedures and advances in minimally invasive techniques. This shift is further bolstered by rising health consciousness among the population and changes in insurance policies that support outpatient treatments, positioning these centers as a preferred choice for many individuals seeking cosmetic enhancements.

    Hospitals and Dermatology Clinics (Dominant) vs. Ambulatory Surgical Centers (Emerging)

    Hospitals and Dermatology Clinics dominate the End User segment due to their comprehensive care capabilities and specialization in cosmetic procedures. These establishments not only offer an extensive range of surgical and non-surgical treatments but also ensure high-quality standards and patient safety. They have established reputations that attract a diverse patient base looking for reassurance and expertise. On the other hand, Ambulatory Surgical Centers represent an emerging force in the market, known for their focus on outpatient procedures. They provide a more patient-friendly environment with lower costs and reduced recovery times, appealing to a younger demographic and those seeking quick results without the need for hospital admissions. This evolving dynamic between traditional and emerging centers is shaping the future landscape of cosmetic surgery.

    Get more detailed insights about North America Cosmetic Surgery Market

    Regional Insights

    US : Leading Market with Diverse Offerings

    The US cosmetic surgery market holds a commanding 18.0% share, valued at approximately $18 billion in 2024. Key growth drivers include increasing consumer awareness, advancements in technology, and a rising trend towards minimally invasive procedures. Regulatory support from the FDA and various state health departments has fostered a favorable environment for innovation. Additionally, robust healthcare infrastructure and a high concentration of skilled professionals contribute to the market's expansion.

    Canada : Expanding Demand for Aesthetic Procedures

    Canada's cosmetic surgery market, with a 3.5% share, is valued at around $3.5 billion as of 2024. The growth is fueled by increasing disposable incomes, a shift in societal norms towards aesthetic enhancement, and a growing aging population seeking rejuvenation. Government regulations are becoming more supportive, with Health Canada ensuring safety and efficacy in cosmetic products. The market is also benefiting from improved healthcare facilities and training programs for practitioners.

    Key Players and Competitive Insights

    The North American cosmetic surgery market is characterized by a dynamic competitive landscape, driven by a confluence of innovation, consumer demand for aesthetic enhancements, and the increasing acceptance of cosmetic procedures. Key players such as Allergan (US), Revance Therapeutics (US), and Galderma (CH) are at the forefront, each adopting distinct strategies to solidify their market positions. Allergan (US), known for its flagship product Botox, continues to focus on innovation and product diversification, while Revance Therapeutics (US) emphasizes its commitment to developing advanced neuromodulators and dermal fillers, thereby enhancing its competitive edge. Galderma (CH), on the other hand, is leveraging strategic partnerships to expand its product offerings and market reach, indicating a trend towards collaborative growth in the sector.

    In terms of business tactics, companies are increasingly localizing manufacturing and optimizing supply chains to enhance efficiency and responsiveness to market demands. The competitive structure of the market appears moderately fragmented, with several players vying for market share. However, the collective influence of major companies like Allergan (US) and Galderma (CH) suggests a trend towards consolidation, as these firms seek to leverage economies of scale and enhance their competitive positioning.

    In October 2025, Allergan (US) announced the launch of a new line of minimally invasive facial rejuvenation products, aimed at capturing the growing demand for non-surgical options. This strategic move not only diversifies Allergan's product portfolio but also positions the company to capitalize on the increasing consumer preference for less invasive procedures, potentially driving significant revenue growth in the coming years.

    In September 2025, Revance Therapeutics (US) secured a partnership with a leading aesthetic clinic chain to expand the distribution of its innovative DaxibotulinumtoxinA injection. This collaboration is likely to enhance Revance's market penetration and brand visibility, reinforcing its position as a key player in the cosmetic surgery market. The partnership underscores the importance of strategic alliances in navigating the competitive landscape.

    In August 2025, Galderma (CH) launched a sustainability initiative aimed at reducing its carbon footprint across its manufacturing processes. This initiative not only aligns with global sustainability trends but also enhances Galderma's brand reputation among environmentally conscious consumers, potentially attracting a new demographic to its product offerings.

    As of November 2025, the competitive trends in the cosmetic surgery market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence in product development and marketing strategies. Strategic alliances are playing a crucial role in shaping the landscape, enabling companies to pool resources and expertise. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on innovation, technological advancements, and supply chain reliability, as companies strive to meet the sophisticated demands of consumers.

    Key Companies in the North America Cosmetic Surgery Market market include

    Industry Developments

    • Q2 2024: Allergan Aesthetics Announces FDA Approval of Skinvive™ by JUVÉDERM® for the Improvement of Cheek Skin Smoothness in Adults Allergan Aesthetics, an AbbVie company, received FDA approval for Skinvive™ by JUVÉDERM®, a hyaluronic acid microdroplet injectable, for improving cheek skin smoothness in adults in the United States.
    • Q2 2024: Cutera Appoints Taylor Harris as Chief Executive Officer Cutera, Inc., a provider of aesthetic and dermatology solutions, announced the appointment of Taylor Harris as its new Chief Executive Officer, effective May 2024.
    • Q2 2024: Revance Announces FDA Approval of DAXXIFY® for the Treatment of Cervical Dystonia Revance Therapeutics received FDA approval for DAXXIFY® (daxibotulinumtoxinA-lanm) for the treatment of cervical dystonia, expanding its neuromodulator portfolio in the U.S. market.
    • Q1 2024: Sientra Announces FDA Approval of New Breast Implant Manufacturing Facility in Wisconsin Sientra, Inc. received FDA approval for its new breast implant manufacturing facility in Wisconsin, aiming to increase production capacity and meet growing demand in the North American cosmetic surgery market.
    • Q1 2024: Alastin Skincare Launches New Procedure Enhancement System for Post-Cosmetic Surgery Recovery Alastin Skincare, a Galderma company, launched a new Procedure Enhancement System designed to support post-cosmetic surgery recovery, targeting clinics and patients in North America.
    • Q2 2024: Allergan Aesthetics Launches JUVÉDERM® VOLUX™ XC for Jawline Enhancement in the U.S. Allergan Aesthetics announced the U.S. launch of JUVÉDERM® VOLUX™ XC, a hyaluronic acid-based injectable gel for jawline enhancement, expanding its facial aesthetics portfolio.
    • Q2 2024: Cutera Launches AviClear™ Acne Device in North America Cutera, Inc. launched AviClear™, a new energy-based device for the treatment of mild to severe acne, in North America, targeting dermatology and cosmetic surgery clinics.
    • Q1 2024: Galderma Announces U.S. FDA Approval of Restylane® Eyelight for the Treatment of Undereye Hollows Galderma received FDA approval for Restylane® Eyelight, a hyaluronic acid filler for the treatment of undereye hollows, expanding its injectable product offerings in the U.S.
    • Q2 2024: Soliton, Inc. Announces Partnership with Aesthetic Solutions for Rapid Acoustic Pulse Technology Soliton, Inc. entered into a partnership with Aesthetic Solutions to distribute its Rapid Acoustic Pulse technology for cellulite and tattoo removal in North America.
    • Q1 2024: Venus Concept Announces FDA Clearance of Venus Bliss Max™ for Non-Invasive Lipolysis Venus Concept received FDA clearance for Venus Bliss Max™, a new device for non-invasive lipolysis of the abdomen and flanks, targeting cosmetic surgery providers in North America.
    • Q2 2024: InMode Ltd. Launches EmpowerRF Platform for Women’s Health and Wellness in the U.S. InMode Ltd. launched EmpowerRF, a new platform for women’s health and wellness procedures, including minimally invasive cosmetic treatments, in the U.S. market.
    • Q1 2024: Apyx Medical Receives FDA 510(k) Clearance for Renuvion® APR Handpiece for Dermal Resurfacing Apyx Medical Corporation received FDA 510(k) clearance for its Renuvion® APR Handpiece, expanding its portfolio of devices for dermal resurfacing procedures in the U.S.

    Future Outlook

    North America Cosmetic Surgery Market Future Outlook

    The cosmetic surgery market is projected to grow at a 7.68% CAGR from 2024 to 2035, driven by technological advancements, increasing consumer awareness, and rising disposable incomes.

    New opportunities lie in:

    • Expansion of telemedicine consultations for pre-surgery assessments.
    • Development of minimally invasive procedures to attract younger demographics.
    • Partnerships with wellness brands for bundled service offerings.

    By 2035, the market is expected to be robust, driven by innovation and evolving consumer preferences.

    Market Segmentation

    North America Cosmetic Surgery Market End User Outlook

    • Hospitals and Dermatology Clinics
    • Ambulatory Surgical Centers
    • Others

    North America Cosmetic Surgery Market Procedure Type Outlook

    • Invasive
    • Non-Invasive

    Report Scope

    MARKET SIZE 202421.5(USD Billion)
    MARKET SIZE 202523.15(USD Billion)
    MARKET SIZE 203548.5(USD Billion)
    COMPOUND ANNUAL GROWTH RATE (CAGR)7.68% (2024 - 2035)
    REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR2024
    Market Forecast Period2025 - 2035
    Historical Data2019 - 2024
    Market Forecast UnitsUSD Billion
    Key Companies Profiled["Allergan (US)", "Galderma (CH)", "Revance Therapeutics (US)", "Medytox (KR)", "Hugel (KR)", "Ipsen (FR)", "Medytox (KR)", "Sientra (US)", "Croma-Pharma (AT)"]
    Segments CoveredProcedure Type, End User
    Key Market OpportunitiesIntegration of advanced technologies enhances patient experience and expands service offerings in the cosmetic surgery market.
    Key Market DynamicsRising consumer demand for minimally invasive procedures drives innovation and competition in the cosmetic surgery market.
    Countries CoveredUS, Canada

    Leave a Comment

    FAQs

    What is the projected growth of the North America Cosmetic Surgery market?

    The North America Cosmetic Surgery market is the expected increase in total market value of 32.79 USD billion over a defined forecast period 2025–2035. It is driven by factors such as demand trends, technological advances, regulatory changes, and geographic expansion.

    What is the size of the North America Cosmetic Surgery market?

    North America Cosmetic Surgery market size was valued at approximately 20.2 billion USD in 2024. This figure will reach 32.79 billion USD covering all regions (America, Europe, Asia, MEA and ROW), focusing its segments / services / distribution channels till 2035.

    What is the CAGR of the North America Cosmetic Surgery market?

    North America Cosmetic Surgery market is expected to grow at a CAGR of 4.5% between 2025 and 2035.

    How much will the North America Cosmetic Surgery market be worth by 2035?

    North America Cosmetic Surgery market is expected to be worth of 32.79 billion USD, reflecting growth driven by usage, technology and global demands by the end of 2035.

    How will the North America Cosmetic Surgery market perform over the next 10 years?

    Over the next 10 years the North America Cosmetic Surgery market is expected to shift from usd billion 20.2 to 32.79 billion USD, led by adoption of advanced tech, demographic trends, regulatory approvals, with potential headwinds from 2025 to 2035.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials

    Compare Licence

    ×
    Features License Type
    Single User Multiuser License Enterprise User
    Price $4,950 $5,950 $7,250
    Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
    Free Customization
    Direct Access to Analyst
    Deliverable Format
    Platform Access
    Discount on Next Purchase 10% 15% 15%
    Printable Versions